I agree that this site is using cookies. You can find further informations here.
X
Calmels, B.
226  results:
Search for persons X
?
1

P1332: PROMISING OUTCOME OF PATIENTS OLDER THAN 70 YEARS WH..:

Harbi, S. ; Brac de la perriere, L. ; Garciaz, S....
HemaSphere.  6 (2022)  - p. 1217-1218 , 2022
Link: https://doi.org/10.1097/..
 
?
2

P1329: POST-TRANSPLANT CYCLOPHOSPHAMIDE (PT-CY) VERSUS ANTI..:

Dachy, F. ; Furst, S. ; Calmels, B....
HemaSphere.  6 (2022)  - p. 1214-1215 , 2022
Link: https://doi.org/10.1097/..
 
?
3

Related versus unrelated allogeneic HPC graft cryopreservat..:

Mfarrej, B. ; Lemarié, C. ; Granata, A....
Bone Marrow Transplantation.  56 (2021)  8 - p. 2013-2015 , 2021
Link: https://doi.org/10.1038/..
 
?
4

Validation of a flow cytometry-based method for quantitativ..:

Mfarrej, B. ; Gaude, J. ; Couquiaud, J....
Cytotherapy.  22 (2020)  5 - p. S155 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Mobilization regimen, including Plerixafor, does not impact..:

Kerjean, E.M. ; Velier, M. ; Mfarrej, B....
Cytotherapy.  22 (2020)  5 - p. S147 , 2020
Link: https://doi.org/10.1016/..
 
?
6

IMPACT OF CLASS II HLA MISMATCH ON CLINICAL OUTCOMES IN HOD..:

Castagna, L. ; Bramanti, S. ; Devillier, R....
Hematological Oncology.  37 (2019)  S2 - p. 300-301 , 2019
Link: https://doi.org/10.1002/..
 
?
7

CAR-T cells : lymphocytes exprimant un récepteur chimérique..:

Chabannon, C. ; Bouabdallah, R. ; Fürst, S....
La Revue de Médecine Interne.  40 (2019)  8 - p. 545-552 , 2019
Link: https://doi.org/10.1016/..
 
?
8

CHECKPOINT INHIBITION BEFORE HAPLOIDENTICAL TRANSPLANTATION..:

de Philippis, C. ; Legrande, F. ; Bramanti, S....
Hematological Oncology.  37 (2019)  S2 - p. 298-299 , 2019
Link: https://doi.org/10.1002/..
 
?
9

Correction: Corrigendum: Disease status is a more reliable ..:

Castagna, L ; Boubdallah, R ; Furst, S...
Bone Marrow Transplantation.  53 (2018)  2 - p. 234-234 , 2018
Link: https://doi.org/10.1038/..
 
?
10

Processing of hematopoietic stem cells grafts: Towards auto..:

Anne-Line, C. ; Gaude, J. ; Malenfant, C....
Cytotherapy.  19 (2017)  5 - p. S50-S51 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Feasibility and safety of allogeneic ex vivo activated-NK c..:

Calmels, B. ; Devillier, R. ; Guia, S....
Cytotherapy.  19 (2017)  5 - p. S16 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Pre-clinical validation of Lovo for post-thaw DMSO depletio..:

Calmels, B. ; Bouchet, G. ; Couquiaud, J....
Cytotherapy.  19 (2017)  5 - p. S50 , 2017
Link: https://doi.org/10.1016/..
 
?
13

Erratum: Highly favorable outcome in BRCA-mutated metastati..:

Boudin, L ; Gonçalves, A ; Sabatier, R...
Bone Marrow Transplantation.  52 (2017)  3 - p. 498-498 , 2017
Link: https://doi.org/10.1038/..
 
?
14

The patient's CMV serological status affects clinical outco..:

Crocchiolo, R ; Castagna, L ; Furst, S...
Bone Marrow Transplantation.  51 (2016)  8 - p. 1134-1136 , 2016
Link: https://doi.org/10.1038/..
 
?
15

Accreditation and regulations in cell therapy:

Chabannon, C. ; Caunday‐Rigot, O. ; Faucher, C....
ISBT Science Series.  11 (2016)  S1 - p. 271-276 , 2016
Link: https://doi.org/10.1111/..
 
1-15